Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Pediatric Crohn's Disease (China, Phase IV)
CTR20200486Phase 4Completed
- Sponsor
- Janssen Biologics B.V.
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by Janssen Biologics B.V.. Started Apr 2020; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on CTR20200486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200486.